Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

NCT07516509
completed

Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test

NCT07554404
completed

Estimating VO2 Max and Recovery

NCT06744582
completednot_applicable

Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?

NCT03809793

Clinical Trials (4)

Showing 4 of 4 trials
NCT07516509

Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

Recruiting
NCT07554404

Comparison of Maximal Oxygen Uptake Obtained Via Seismofit and Cardiopulmonary Exercise Test

Completed
NCT06744582

Estimating VO2 Max and Recovery

Completed
NCT03809793Not Applicable

Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4